QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Meditsiinilised instrumendid ja tarvikud

Mr. Michael S. Iskra

Interim Chief Executive Officer, Executive Vice President & Chief Commercial Officer

Mr. Patrick E. Klein

Chief Administrative Officer

Mr. Robert J. Bujarski J.D.

Interim President, Executive Vice President & Chief Operating Officer

Ms. Michelle A. Hodges

Senior Vice President, General Counsel & Secretary

Ms. Louise M. Brandy

Chief Information Officer

Mr. Joseph M. Busky CPA

Chief Financial Officer

Ms. Tamara A. Ranalli

Molecular Diagnostics Business Unit Leader

Mr. William J. Ferenczy

Point of Care Business Unit Leader

Dr. Werner  Kroll Ph.D.

Senior Vice President of Research & Development

Ruben  Argueta

Director of Investor Relations

Nimi	Turukapitali suurus
KMA Holding, Inc.	0M
INSPECS Group plc	0M
IVF Hartmann Holding AG	0M
Tecan Group AG	0M
Shandong Weigao Group Medical Polymer Company Limited	0M
iZafe Group AB (publ)	0M
Yubo International Biotech Limited	0M
Ansell Limited	0M
Pixium Vision SA	0M
LeMaitre Vascular, Inc.	0M
Terumo Corporation	0M

QuidelOrtho Corporation

QuidelOrtho Corporation Konkurentide nimekiri

Peamised konkurendid